Refine
Has Fulltext
- yes (50)
Is part of the Bibliography
- yes (50)
Year of publication
Document Type
- Journal article (50)
Keywords
- prostate cancer (7)
- DNA damage (6)
- radiotherapy (6)
- Medizin (5)
- IGRT (3)
- Radiosurgery (3)
- glioblastoma multiforme (3)
- head and neck cancer (3)
- hypofractionation (3)
- long-term outcome (3)
- radiosensitivity (3)
- DNA repair (2)
- DNA-PK (2)
- Glioblastoma (2)
- Halcyon (2)
- Image-guidance (2)
- NSCLC (2)
- NVP-BEZ235 (2)
- PTEN (2)
- Radiotherapy (2)
- Stereotactic body radiotherapy (2)
- Strahlentherapie (2)
- VMAT (2)
- apoptosis (2)
- autophagy (2)
- cell cycle arrest (2)
- cone beam CT (2)
- histone H2AX (2)
- hypoxia (2)
- image-guided radiation therapy (2)
- metastasis-directed therapy (2)
- migration (2)
- oligorecurrence (2)
- osteopontin (2)
- p53 (2)
- radiation sensitivity (2)
- rectal cancer (2)
- salvage radiotherapy (2)
- simultaneous integrated boost (2)
- toxicity (2)
- 3D conformal silicone bolus (1)
- 3D printer (1)
- 4D-MRI (1)
- ADT (1)
- ATM (1)
- AZD6244 (1)
- Adaptation (1)
- Akt (1)
- Androgendeprivationstherapie (1)
- Automated analysis (1)
- Brain cancer (1)
- CD133 (1)
- CIED malfunction; pacemaker (PM) (1)
- CNS cancer (1)
- Combination (1)
- Cone-beam CT (1)
- Corticosteroids (1)
- DNA double strand breaks (1)
- DNA double-strand breaks (1)
- DNA repair protraction (1)
- DNS-Reparatur (1)
- DNS-Schädigung (1)
- EBRT (1)
- Extended field irradiation (1)
- Follicular lymphoma (1)
- Frame-based (1)
- Frame-less (1)
- Glioma stem cells (1)
- Head and neck cancer (1)
- High grade glioma (1)
- Histone gamma H2AX (1)
- IMAT (1)
- IMRT (1)
- IR (1)
- ImageJ plugin (1)
- Improved survival (1)
- Inter-observer variability (1)
- Ionizing radiation (1)
- Locoregional recurrence (1)
- Lung cancer (1)
- Meningioma (1)
- N-Myc down regulated gene 1 (1)
- Nachruf (1)
- Nestin (1)
- Non-rigid image registration (1)
- Normal tissue tolerance (1)
- Novel PI3K (1)
- Open-source tool (1)
- Osteopontin (1)
- PBRT (1)
- PI3K (1)
- PLNRT (1)
- PRRT (1)
- PSMA (1)
- PSMA PET/CT (1)
- Pain (1)
- Pelvic tumors (1)
- Peptide receptor radionuclide therapy (1)
- Peripheral blood lymphocytes (1)
- Phase II trial (1)
- Prostataloge (1)
- Prostate carcinoma (1)
- Radiation biology (1)
- Radiation sensitivity (1)
- Radiosensitivity (1)
- Radiotherapy treatment planning (1)
- Re-irradiation (1)
- Rectal cancer (1)
- Respiration correlated imaging (1)
- Respiratory induced tumor motion (1)
- Salvage-Radiotherapie (1)
- Short dsRNA oligonucleotides (1)
- Spinal metastases (1)
- Spinal metastasis (1)
- Step and Shoot IMRT (1)
- Stereotactic (1)
- Synergy (1)
- TGFβ1 (1)
- TME (1)
- Temozolomide (1)
- Total nodal irradiation (1)
- Werner Bohndorf (1)
- \(\gamma\)h2ax (1)
- acute toxicity (1)
- adaptation (1)
- adaptive radiotherapy (1)
- androgen deprivation therapy (1)
- anxiety (1)
- auto-planning (1)
- battery depletion (1)
- biochemical relapse free survival (1)
- blood lymphocytes (1)
- brain cancer (1)
- cancer (1)
- capacitance (1)
- cardiac implantable electronic devices (CIED) (1)
- cardiac resynchronization therapy (CRT) (1)
- cell membranes (1)
- chemotherapy (1)
- colony survival (1)
- cone-beam ct (1)
- deformable image registration (1)
- depression (1)
- dominant intraprostatic lesion (1)
- dose accumulation (1)
- dose escalation (1)
- dose evaluation (1)
- dose to OARs (1)
- double arc (1)
- external beam radiotherapy (EBRT) (1)
- flat silicone bolus (1)
- foci (1)
- full arc (1)
- fused deposition modeling (FDM) (1)
- gamma H2AX-foci (1)
- guidance (1)
- head (1)
- helical tomotherapy (1)
- high-dose-rate (HDR) brachytherapy (1)
- high-dose-rate brachytherapy boost (1)
- histone γH2AX (1)
- hospital-based palliative care (1)
- human cancer diseases (1)
- hypotonic (1)
- implantable cardioverter defibrillator (ICD) (1)
- in vivo (1)
- individual radiosensitivity (1)
- individual silicone bolus (1)
- intensity-modulated radiation therapy (1)
- irradiation (1)
- irridation (1)
- isotonic (1)
- limitations (1)
- local control (1)
- lung cancer (1)
- lymph node metastases (1)
- mTOR (1)
- mTOR Inhibitor (1)
- macroscopic recurrence (1)
- megavoltage computed-tomography (1)
- membrane characteristics (1)
- membrane proteins (1)
- microvilli (1)
- multimodal therapy (1)
- multiple brain metastases (1)
- neck cancer (1)
- oligmometastases (1)
- optimization (1)
- oral mucositis (1)
- outcomes research (1)
- partial arc (1)
- patient-reported outcome (1)
- pelvic lymph node radiotherapy (1)
- pelvine Lymphabflüsse (1)
- perioperative changes (1)
- peripheral blood lymphocytes (1)
- phosphorylation (1)
- plan comparison (1)
- propensity score matching (1)
- prostate Imaging Reporting and Data System (1)
- prostate bed radiotherapy (1)
- prostate-cancer (1)
- quaility indicator (1)
- radiation therapy (1)
- radiosensibility (1)
- radiotherapy (RT) (1)
- re-irradiation (1)
- re-planning (1)
- repair (1)
- scanning electron microscopy (1)
- setup verification (1)
- single arc (1)
- stereotactic body radiotherapy (1)
- surface dose measurement (1)
- survival (1)
- therapy (1)
- thoracic cancer (1)
- transperineal ultrasound (1)
- treatment (1)
- treatment plan (1)
- volumetric modulated arc therapy (VMAT) (1)
- whole breast irradiation (1)
- wound healing (1)
Institute
- Klinik und Poliklinik für Strahlentherapie (48)
- Theodor-Boveri-Institut für Biowissenschaften (9)
- Comprehensive Cancer Center Mainfranken (3)
- Klinik und Poliklinik für Nuklearmedizin (3)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
- Medizinische Klinik und Poliklinik II (2)
- Pathologisches Institut (2)
- Frauenklinik und Poliklinik (1)
- Institut für Geschichte der Medizin (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
Background
The prognostic value of histone γ-H2AX and 53BP1 proteins to predict the radiotherapy (RT) outcome of patients with rectal carcinoma (RC) was evaluated in a prospective study. High expression of the constitutive histone γ-H2AX is indicative of defective DNA repair pathway and/or genomic instability, whereas 53BP1 (p53-binding protein 1) is a conserved checkpoint protein with properties of a DNA double-strand breaks sensor.
Methods
Using fluorescence microscopy, we assessed spontaneous and radiation-induced foci of γ-H2AX and 53BP1 in peripheral blood mononuclear cells derived from unselected RC patients (n = 53) undergoing neoadjuvant chemo- and RT. Cells from apparently healthy donors (n = 12) served as references.
Results
The γ-H2AX assay of in vitro irradiated lymphocytes revealed significantly higher degree of DNA damage in the group of unselected RC patients with respect to the background, initial (0.5 Gy, 30 min) and residual (0.5 Gy and 2 Gy, 24 h post-radiation) damage compared to the control group. Likewise, the numbers of 53BP1 foci analyzed in the samples from 46 RC patients were significantly higher than in controls except for the background DNA damage. However, both markers were not able to predict tumor stage, gastrointestinal toxicity or tumor regression after curative RT. Interestingly, the mean baseline and induced DNA damage was found to be lower in the group of RC patients with tumor stage IV (n = 7) as compared with the stage III (n = 35). The difference, however, did not reach statistical significance, apparently, because of the limited number of patients.
Conclusions
The study shows higher expression of γ-H2AX and 53BP1 foci in rectal cancer patients compared with healthy individuals. Yet the data in vitro were not predictive in regard to the radiotherapy outcome.